Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Sime, R. Barnes, S. Elson, R. Jarvest, K. O'Toole (1992)
Chemoenzymatic approach to the synthesis of the antiviral agents penciclovir and famciclovir in isotopically chiral [13C] labelled formJournal of The Chemical Society-perkin Transactions 1, 13
D. Earnshaw, T. Bacon, S. Darlison, K. Edmonds, R. Perkins, R. Hodge (1992)
Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 36
A. Larsson, K. Stenberg, A. Ericson, U. Haglund, W. Yisak, N. Johansson, B. Oberg, Roelf DATEMAl (1986)
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovirAntimicrobial Agents and Chemotherapy, 30
(1973)
DHPG) with improved oral absorption
K. Stenberg, A. Larsson, R. Datema (1986)
Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.The Journal of biological chemistry, 261 5
(1993)
Update on Famciclovir
(1987)
1987)Selection of a derivative
Y. Mul, R. Miltenburg, E. Clercq, P. Vliet (1989)
Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein.Nucleic acids research, 17 22
R. Hodge, David Sutton, R. Malcolm, Boyd, M. Harnden, R. Jarvest (1989)
Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Antimicrobial Agents and Chemotherapy, 33
(1973)
Replication - biochemical aspects
(1989)
1989a) Mode of action
(1989)
Structural requirements for enzymatic acti
Phillip Furman, P. Mcguirt, Paul Keller, J. Fyfe, G. Elion (1980)
Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information.Virology, 102 2
C. Winton, S. Fowles, D. Pierce, A. Hodge (1990)
Gradient high-performance liquid chromatographic method for the analysis of the pro-drug famciclovir and its metabolites, including the active anti-viral agent penciclovir, in plasma and urine, 27
J. Hannah, R. Tolman, J. Karkas, R. Liou, H. Perry, A. Field (1989)
Carba-acyclonucleoside antiherpetic agentsJournal of Heterocyclic Chemistry, 26
John, Reardon, Thomas Spector (1989)
Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate.The Journal of biological chemistry, 264 13
M. O’Donnell, P. Elias, I. Lehman (1987)
Processive replication of single-stranded DNA templates by the herpes simplex virus-induced DNA polymerase.The Journal of biological chemistry, 262 9
(1990)
Use of isoptopically chiral [ 4 '13 C ] penciclovir ( BRL 39123 ) and its oral prodrug [ 4 '13 C ] famciclovir ( BRL 42810 ) to determine the absolute configuration of their metabolites
Assay of famciclovir and its metabolites . including the , antiherpes agent penciclovir , in plasma and urine of rat , dog and man
R. Jarvest, R. Barnes, D. Earnshaw, K. O'Toole, J. Sime, R. Hodge (1990)
Synthesis of isotopically chiral [13C]penciclovir (BRL 39123) and its use to determine the absolute configuration of penciclovir triphosphate formed in herpes virus infected cellsJournal of The Chemical Society, Chemical Communications
R. Hodge, R. Perkins (1989)
Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsAntimicrobial Agents and Chemotherapy, 33
M. Boyd, T. Bacon, D. Sutton (1987)
Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureAntimicrobial Agents and Chemotherapy, 31
P. Miranda, M. Blum (1983)
Pharmacokinetics of acyclovir after intravenous and oral administration.The Journal of antimicrobial chemotherapy, 12 Suppl B
T. Krenitsky, Joel Tuttle, Edward Cattau, Patsy Wang (1974)
A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase.Comparative biochemistry and physiology. B, Comparative biochemistry, 49 4
A. Karlsson, J. Harmenberg, B. Wahren (1986)
Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1Antimicrobial Agents and Chemotherapy, 29
K. Biron, G. Elion (1980)
In vitro susceptibility of varicella-zoster virus to acyclovirAntimicrobial Agents and Chemotherapy, 18
G. Elion, P. Furman, J. Fyfe, P. Miranda, L. Beauchamp, H. Schaeffer (1977)
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.Proceedings of the National Academy of Sciences of the United States of America, 74 12
W. Miller, Richard Miller (1982)
Phosphorylation of acyclovir diphosphate by cellular enzymes.Biochemical pharmacology, 31 23
J. Karkas, J. Germershausen, R. Tolman, M. Maccoss, A. Wagner, R. Liou, R. Bostedor (1987)
Stereochemical considerations in the enzymatic phosphorylation and antiviral activity of acyclonucleosides. I. Phosphorylation of 2'-nor-2'-deoxyguanosine.Biochimica et biophysica acta, 911 2
(1992)
Activity of penciclovir and acyclovir in DBA / 2 mice infected intraper - itoneally with HSV - 1 ( SC 16 )
M. Boyd, T. Bacon, D. Sutton (1988)
Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsAntimicrobial Agents and Chemotherapy, 32
T. Krenitsky, Willard Hall, P. Miranda, L. Beauchamp, H. Schaeffer, Paul WHITEMANt (1984)
6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Proceedings of the National Academy of Sciences of the United States of America, 81 10
(1990)
1990b and Figure 8 from Jarvest et al., 1990 with the permission of The Royal Society of Chemistry
Some biological properties of BRL 42810 , a well absorbed prodrug of the antiherpes virus agent BRL 39123
(1990)
1990)Synthesis of isotopically chiral
R. Datema, A. Ericson, H. Field, A. Larsson, K. Stenberg (1987)
Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs.Antiviral research, 7 6
M. Harnden, R. Jarvest, M. Boyd, D. Sutton, R. Hodge (1989)
Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties.Journal of medicinal chemistry, 32 8
J. Gottlieb, A. Marcy, D. Coen, M. Challberg (1990)
The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivityJournal of Virology, 64
B Hurn, E. Andrews (1987)
Oral acyclovir in acute herpes zosterBritish Medical Journal (Clinical research ed.), 294
Famciclovir is the oral form of penciclovir, a highly selective antiherpesvirus agent. Both famciclovir and penciclovir are being evaluated in clinical studies. This review covers the conversion of famciclovir to penciclovir, the formation and stability of penciclovir-triphosphate, its effect on herpesvirus DNA polymerases and the inhibition of viral DNA synthesis in cell cultures. The conversion of famciclovir into penciclovir is described, emphasising work with human tissues and including the elucidation of the structures of its chiral monoacetylated derivatives. To reflect its metabolism during oral absorption, famciclovir was incubated in duodenal contents, extracts of intestinal wall and liver, and in blood. The major metabolic route was by de-acetylation followed by oxidation of the purine to form penciclovir. This work with human tissues was predictive of the major metabolic pathway in humans. Penciclovir is phosphorylated much more efficiently than acyclovir in herpesvirus-infected cells yet the host cell kinases phosphorylate the two compounds to a small but comparable extent. This highly preferential metabolism in herpesvirus infected cells is a major factor in its selective antiviral activity. The (S) enantiomer of penciclovir-triphosphate is the major metabolite and it has good stability in HSV-1, HSV-2, and VZV infected cells. At the high concentrations found in infected cells, penciclovir-triphosphate was an effective inhibitor of viral DNA polymerases and of viral DNA synthesis. The efficient entrapment of the active moiety can account for the markedly better antiviral activity of penciclovir than acyclovir when infected cell cultures were treated for a short time. Such assays reflect more closely the clinical situation after oral dosing than do standard assays in which the test compounds are present continuously. The role of these studies in compound selection and development is discussed.
Antiviral Chemistry and Chemotherapy – SAGE
Published: Jun 24, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.